Español  |  English
Home    |    Bioiberica People    |    Site Map    |    Contact   RSS | Bioiberica
Bringing ideas to life | Bioiberica
About Bioiberica Products Bioiberica Structure News & Events

Última actualización:
11 de junio de 2013
Our objective is to achieve license agreements, joint ventures in our Business areas (ethical; nutraceutical; veterinary) and also to reach worldwide strategic agreements. Within the area of healthcare we specialise in joint health care; we also aim to be present at the digestive [products] sector.

Contact
- In-, out-licensing for the Spanish territory:

 • OUT licensing: combination; chondroitin sulphate; glucosamine sulphate.
 • IN Licensing: products for the osteoarticular and digestive areas.

- International businesses to be implemented by the International and Joint Care divisions.

- Collaboration with universities, with the pharmaceutical & biotechnological industry, and with public administrations.
IPS
IPS is a semi-synthetic polysaccharide with a potential modifying effect of articular cartilage pathobiology.
+ more information
BIS014
BIS014 is a synthetic disaccharide obtained as a result of Bioiberica’s research in new pharmaceutical entities combining potent anti-inflammatory efficacy and collagen protection in cartilage and tendons.
+ more information
Home - Legal Notice - Privacy Policy - Site Map
Copyright 2013. Bioiberica. All rights reserved. Last update: 11 de junio de 2013